IVEN keen to become healthcare investment major
ICICI Venture, the largest domestic private equity fund, is all set to sign a deal with a foreign strategic investor in its endeavor to become a health care investment major in the country.
Say something
ICICI Venture, the largest domestic private equity fund, is all set to sign a deal with a foreign strategic investor in its endeavor to become a health care investment major in the country.
Drug maker Wockhardt has announced it will spin off its R&D business and list the new company on stock exchange on January 1, 2009. The company thus has followed similar moves by other pharma companies, who have hived off their research and development units.
Private equity (PE) major ICICI Ventures is acquiring Chennai-based standalone pharmaceutical and
veterinary company Alved Pharma and Foods. RFCL, a wholly-owned veterinary, chemicals and medical
diagnostic company of ICICI Ventures, is learnt to have signed a definitive agreement with Alved Pharma and Foods for a complete buyout.
[This article was published in the January 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News
[This article was published in the January 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News
US-based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.
ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund
ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund
[This article was published in the December 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News Review
[This article was published in the December 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News Review
US-based private equity fund Citi Venture Capital (CVC) has picked up nearly 30% stake in Mumbai-based bulk drug maker Unimark Remedies for INR 113 crore. The transaction, one of the largest investments in the pharma sector in 2007 and CVC